INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Lecanemab and Donanemab After 1 Year: Early Lessons

Save Like Comments Compare coverage

Summary

German memory clinics report no new safety signals with lecanemab and donanemab, while clinicians stress patient selection, MRI monitoring, and treatment early in disease. Medscape News Europe

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Lecanemab and Donanemab After 1 Year: Early Lessons

    German memory clinics report no new safety signals with lecanemab and donanemab, while clinicians stress patient selection, MRI monitoring, and treatment early in disease. Medscape News Europe

Comments

Comments need JavaScript.